Modern wound dressings can be produced efficiently and sustainably from just three components if the Baymedix® and Platilon® materials are combined appropriately. The direct application of the adhesive or foam to the film eliminates laminating steps. Wound dressings based on the Covestro PU technology are also well suited for advanced negative pressure wound therapy.
“Our Baymedix® product portfolio enables us to fulfill the desire of many manufacturers to generate added value through innovation and differentiation, and to thus improve their own competitiveness,” says Martin Huettner, Marketing Manager Medical at Covestro. “This is difficult to achieve with the established raw materials on the market.”
The differences are particularly pronounced when it comes to moisture management. Wound dressings made from Covestro materials are air-permeable, exhibit a high absorption capacity and outstanding retention. In addition, the adjustable adhesive strengths of adhesives based on Baymedix® technology make “low trauma removal” – an important issue in wound care – readily achievable.
With 2015 sales of EUR 12.1 billion, Covestro is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. Covestro, formerly Bayer MaterialScience, has 30 production sites around the globe and as of the end of the first quarter 2016 employed approximately 15,700 people (full-time equivalents).
This press release is available for download from the Covestro press server at www.covestro.com. Photos are available there for download as well. Please mind the source of the pictures.
Find more information at www.covestro.com.
Follow us on Twitter: www.twitter.com/CovestroGroup